Viso Clinical

VISO Clinical sprl is wholly committed to providing unwavering support to Clinical Research Organizations (CROs), Laboratories, Biotechs, and Pharmaceutical companies in revolutionary facets pertaining to preclinical and clinical research endeavors. Dedicated to fostering groundbreaking approaches and ventures in novel technologies and processes within clinical trials, VISO Clinical champions the integration of Blockchain in Clinical Trials as one of its recent areas of focus. OSHIMED has been created with the goals to supporting new disruptive approaches in the area of clinical trials and healthcare, thanks to the development of innovative solutions using Blockchain. The Blockchain network presents an unparalleled paradigm shift, placing patients at the very heart of clinical research by granting them ownership of their health data. This visionary approach rekindles trust in the realm of clinical trials, obviating the need for cumbersome and opaquely orchestrated procedures through which pharmaceutical companies presently collect invaluable health data to monitor the safety and efficacy of investigational drugs. Regarded by numerous stakeholders in clinical trials as an extraordinary opportunity, Blockchain establishes an unassailable standard of transparency and engagement in relationships with patients and regulatory bodies alike. Through real-time monitoring of the effects of drugs and just compensation for active patient involvement in clinical research, Blockchain revolutionizes the landscape. VISO Clinical wholeheartedly supports the Clinical Trials Community in embracing this transformative approach by offering its combined expertise in Blockchain and Clinical Trials. We assist CROs, Bio & Pharma companies in developing their comprehension and strategies within this pioneering model through an inclusive and consultative approach, engendering comprehensive solutions that transcend conventional boundaries.